Gainers
- Cemtrex, Inc. CETX shares rose 71.1% to $2.5999 after the company reported Q3 sales up from last year.
- iBio, Inc. IBIO shares climbed 66.4% to $1.165 after the company announced an agreement with United Therapeutics to produce recombinant human collagen-based bioink for 3D bioprinted organ transplants.
- Endo International plc ENDP climbed 28.2% to $3.2685 after the company announced a settlement to resolve the "Track 1" opioid cases. The settlement will resolve Track 1 cases which assert claims relating to manufacturing, marketing, distribution, etc.
- Cheetah Mobile Inc. CMCM gained 22.4% to $4.04 after the company reported better-than-expected Q2 sales results.
- VIVUS, Inc. VVUS rose 19.7% to $4.07. VIVUS highlighted study results showing that the addition of company's Qsymia to gastric sleeve surgery significantly improves weight loss compared with surgery alone.
- Tonix Pharmaceuticals Holding Corp TNXP rose 13.7% to $0.5367 after the company was granted an exclusive license from Wayne State University for technology and patents related TNX-1600.
- 21Vianet Group, Inc. VNET gained 12.7% to $7.91 after the company reported better-than-expected Q2 sales results.
- RADA Electronic Industries Ltd. RADA rose 10.5% to $4.51.
- CPI Card Group Inc. PMTS climbed 10.5% to $3.1499.
- Hilton Grand Vacations Inc. HGV shares rose 9.9% to $31.00 after NY Post reported that Apollo Global Management could offer as much as $36 per share for Hilton Grand Vacations.
- Avaya Holdings Corp. AVYA gained 9.7% to $13.64 after Reuters reported the company may be considering an all-cash sale to a private equity firm as an alternative to a potential merger with Mitel.
- Ardelyx, Inc. ARDX shares rose 9.4% to $3.25.
- Ideal Power Inc. IPWR surged 9.3% to $3.06.
- Atlanticus Holdings Corporation ATLC gained 9% to $8.93.
- Teva Pharmaceutical Industries Limited TEVA shares surged 8.2% to $7.26 after the company announced a generic EpiPen Jr in the U.S.
- Baidu, Inc. BIDU rose 7.9% to $112.45 after the company reported better-than-expected results for its second quarter.
- the Rubicon Project, Inc. RUBI climbed 7.8% to $10.54
- Perion Network Ltd. PERI gained 7.5% to $6.72.
- Moderna Inc MRNA rose 7% to $14.34 after the company announced the FDA has granted Fast Track designation for its investigational Zika vaccine mRNA-1893.
- Titan Medical Inc. TMDI gained 7% to $2.3538.
- Beyond Meat, Inc. BYND rose 6.3% to $153.56 after JP Morgan upgraded the company's stock from Neutral to Overweight.
- Medtronic PLC MDT rose 4.7% to $109.05 after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY20 EPS guidance above analyst estimates.
- Home Depot Inc HD rose 4.4% to $217.03 after the company reported better-than-expected Q2 EPS results.
- Seadrill Limited SDRL rose 4.2% to $2.8230 after the company reported better-than-expected Q2 EPS and sales results.
Check out these big penny stock gainers and losers
Losers
- ToughBuilt Industries, Inc. TBLT dropped 34.2% to $0.3650 after the company reported Q2 earnings results.
- Synlogic, Inc. SYBX fell 29.4% to $3.41 after the company discontinued the development of SYNB1020 to treat hyperammonemia.
- NuCana plc NCNA shares dropped 19.4% to $5.90 after the company suspended enrollment in independent investigator-sponsored Phase III metastatic pancreatic study ACELARATE following a prespecified futility analysis.
- Fabrinet FN declined 14.8% to $48.13. Fabrinet reported stronger-than-expected results for its fourth quarter, but issued weak outlook for the first quarter.
- Sarepta Therapeutics, Inc. SRPT shares fell 14.2% to $103.24 after the company announced it had received a complete response letter from the FDA regarding the new drug application seeking accelerated approval of Golodirsen.
- TrovaGene, Inc. TROV fell 11% to $2.67 session after gaining 43.54% on Monday.
- Sea Limited SE shares fell 10.6% to $32.26 after reporting Q2 results.
- Novavax, Inc. NVAX shares declined 10.2% to $6.55.
- The Hain Celestial Group, Inc. HAIN fell 10% to $19.72 after JP Morgan downgraded the stock from Neutral to Underweight and lowered the price target from $23 to $18 per share.
- Melinta Therapeutics, Inc. MLNT dropped 9.1% to $2.4454.
- ATA Inc. ATAI shares tumbled 8.9% to $1.85.
- Plus Therapeutics, Inc. PSTV fell 8.2% to $8.26 after declining 37.67% on Monday.
- AnaptysBio, Inc. ANAB dipped 7.8% to $45.05.
- The Madison Square Garden Company MSG shares dropped 7.7% to $270.83 after the company reported worse-than-expected Q4 EPS and sales results.
- Briggs & Stratton Corporation BGG dipped 7.7% to $4.56.
- Montage Resources Corporation MR shares declined 7.6% to $3.17.
- Elanco Animal Health Incorporated ELAN fell 7.2% to $27.67. Elanco Animal Health announced a deal to buy Bayer's animal health business in a transaction valued at $7.6 billion in cash and stock.
- California Resources Corporation CRC dipped 6.5% to $9.37.
- Yuma Energy Inc YUMA shares fell 5% to $2.85 after surging 141.94% on Monday.
- DPW Holdings, Inc. DPW fell 4.8% to $4.5698 after climbing 133.01% on Monday. DPW Holdings posted Q2 revenue of $6.148 million and operating loss of $3.969 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in